Login / Signup

Immobility-associated thromboprotection is conserved across mammalian species from bear to human.

Manuela ThienelJohannes B MüllerZhe ZhangVincent EhreiserJudith HuthKhrystyna ShchurovskaBadr KilaniLisa SchweizerPhilipp E GeyerMaximilian ZwiebelJulia NovotnyEnzo LüsebrinkGemma LittleMartin OrbanLeo NicolaiShaza El NemrAnna TitovaMichael SpannaglJonas KindbergAlina L EvansOrpheus MachMatthias VogelSteffen TiedtSteffen OrmannsBarbara KesslerAnne DueckAndrea FriebePeter Godsk JørgensenMonir Majzoub-AltweckAndreas BlutkeAmin PolzinKonstantin StarkStefan KääbDoris MaierJonathan M GibbinsUlrich LimperOle FröbertMatthias MannSteffen MassbergTobias Petzold
Published in: Science (New York, N.Y.) (2023)
Venous thromboembolism (VTE) comprising deep venous thrombosis and pulmonary embolism is a major cause of morbidity and mortality. Short-term immobility-related conditions are a major risk factor for the development of VTE. Paradoxically, long-term immobilized free-ranging hibernating brown bears and paralyzed spinal cord injury (SCI) patients are protected from VTE. We aimed to identify mechanisms of immobility-associated VTE protection in a cross-species approach. Mass spectrometry-based proteomics revealed an antithrombotic signature in platelets of hibernating brown bears with heat shock protein 47 (HSP47) as the most substantially reduced protein. HSP47 down-regulation or ablation attenuated immune cell activation and neutrophil extracellular trap formation, contributing to thromboprotection in bears, SCI patients, and mice. This cross-species conserved platelet signature may give rise to antithrombotic therapeutics and prognostic markers beyond immobility-associated VTE.
Keyphrases